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Abstract
The IgM-Fc receptor (FcμR) is involved in IgM homeostasis as evidenced by increased pre-immune 
serum IgM and natural auto-antibodies of both IgM and IgG isotypes in Fcmr-deficient C57BL/6 
(B6) mice. To determine the impact of Fcmr-ablation on autoimmunity, we introduced the Fcmr null 
mutation onto the Fas-deficient autoimmune-prone B6.MRL Faslpr/lpr mouse background (B6/lpr).  Both 
IgM and IgG auto-antibodies against dsDNA or chromatin appeared earlier in FcμR(−) B6/lpr than 
FcμR(+) B6/lpr mice, but this difference became less pronounced with age. Splenic B2 cells, which 
were 2-fold elevated in FcμR(+) B6/lpr mice, were reduced to normal B6 levels in FcμR(−) B6/lpr mice, 
whereas splenic B1 cells were comparable in both groups of B6/lpr mice. By contrast, marginal zone 
(MZ) B cells were markedly reduced in FcμR(−) B6/lpr mice compared with either FcμR(+) B6/lpr or 
wild type (WT) B6 mice. This reduction appeared to result from rapid differentiation of MZ B cells 
into plasma cells in the absence of FcμR, as IgM antibody to a Smith (Sm) antigen, to which MZ B 
cells are known to preferentially respond, was greatly increased in both groups (B6/lpr and B6) of 
FcμR(−) mice compared with FcμR(+) B6/lpr or B6 mice. Mott cells, aberrant plasma cells with intra-
cytoplasmic inclusions, were also increased in the absence of FcμR. Despite these abnormalities, 
the severity of renal pathology and function and survival were all indistinguishable between FcμR(−) 
and FcμR(+) B6/lpr mice. Collectively, these findings suggest that FcμR plays important roles in the 
regulation of auto-antibody production, Mott cell formation and the differentiation of MZ B cells into 
plasma cells in B6.MRL Faslpr/lpr mice.
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Introduction
Antibody has dual binding activities, to antigen via its amino 
terminal variable regions and to effector molecules such as 
Fc receptors (FcRs) via its carboxy terminal constant regions. 
Among the five different antibody isotypes, IgM appears first 
during phylogeny, ontogeny and immune responses and is the 
first line of defense against pathogens (1). IgM exists as a mem-
brane-bound, monomeric form on the surface of B cells and as 
a secreted, mostly pentameric form with a mushroom-like shape 
(2). Both pre-immune ‘natural’ and antigen-induced “immune” 
IgM antibodies are important for protection against infection and 
autoimmunity by recognizing pathogens as well as self-antigens 
associated with host cell corpses (1). FcRs for switched immu-
noglobulin classes (i.e. FcγRs, FcεRs and FcαR) have been 
extensively characterized at both protein and genetic levels (3). 
Although there was biochemical evidence of an FcR for IgM 
(FcμR) for decades (4–6), the gene encoding this receptor 
(FCMR) defied identification until its recent functional cloning 
by our group (7). FcμR is a transmembrane sialoglycoprotein 
of ~60 kD with a single immunoglobulin-like domain that con-
fers exclusive binding specificity for the Fc region of IgM. FcμR 
binds IgM pentamers with a strikingly high avidity of ~10 nM (7). 
Upon IgM binding, FcμR is rapidly internalized into the lysoso-
mal compartment (8). Unlike other FcRs, FcμR is expressed by 
lymphocytes: B, T and NK cells in humans (7, 9) and B cells 
only in mice (10–12), though there are conflicting data con-
cerning the faint expression of FcμR by mouse granulocytes 
and macrophages (13–15). FCMR was originally designated 
Toso or Fas apoptotic inhibitory molecule 3 (FAIM3) (16). 
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However, the original apoptotic assay leading this designa-
tion was performed with an agonistic anti-Fas mAb with an IgM 
isotype (16). The results from subsequent analyses by us and 
others clearly demonstrated that the Toso/FAIM3 designation 
is incorrect and that this gene instead encodes an authentic 
IgM Fc-binding receptor (7–9, 17). FCMR is a single copy gene 
located on chromosome 1q32.2, adjacent to two other IgM-
binding receptor genes: polymeric Ig receptor (PIGR) and FcR 
for IgA and IgM (FCAMR) (7).
Fcmr-deficient [knockout (KO)] mice have been indepen-
dently generated by three laboratories (K. H.  Lee, Leibniz 
Center for Medicine and Biosciences, Borstel, Germany; 
H. Ohno, RIKEN, Yokohama, Japan; and T. W. Mak, Ontario 
Cancer Institute, Toronto, Canada) and have recently been 
characterized by five different groups, and there are clear 
differences in the reported phenotypes (11–13, 18, 19). 
Nevertheless, the abnormal phenotypes commonly observed 
in Fcmr KO mice are (i) alterations in B-cell subpopulations, 
(ii) dysregulation of humoral immune responses, (iii) impair-
ment of B-cell proliferation upon ligation of BCR in vitro and 
(iv) predisposition to auto-antibody production (11, 12, 19). 
Notably, many abnormalities in FcμR KO mice mirror those 
observed in μs exon-targeted mice (μs−/−), which are able to 
express surface IgM and other immunoglobulin isotypes on 
B cells and to secrete all other classes of immunoglobulin 
except for IgM. Together, these observations emphasize the 
critical role in normal B cell functions both for secreted IgM 
and for its interaction with FcμR (1). Interestingly, pre-immune 
serum IgM and IgG3 are significantly elevated in Fcmr KO 
mice (11, 12). By contrast, serum IgM levels are unaffected in 
naive mice with null mutations of two other IgM-binding recep-
tors, the pIgR on mucosal epithelial cells and the Fcα/μR on 
follicular dendritic cells (FDCs) (20, 21). Thus, FcμR appears 
to be the sole receptor in this family that is involved in IgM 
homeostasis. Fcmr KO mice also develop high levels of nat-
ural auto-antibodies of both IgM and IgG isotypes at 13–18 
weeks of age (11, 12).
Autoreactive B cells play a critical role in the pathogenesis 
of systemic lupus erythematosus (SLE), which is characterized 
by circulating auto-antibodies and deposition of the resulting 
immune complexes in various tissues, particularly the kidneys, 
leading to glomerulonephritis. The importance of FcRs, espe-
cially the inhibitory FcγRIIb, in influencing the development 
of autoimmunity is suggested in mouse model systems and 
also seems to be the case for humans, as shown by analy-
ses of large cohorts of autoimmune patients (22). For example, 
memory B cells in SLE patients fail to up-regulate cell surface 
FcγRIIb, and this is correlated with a reduced threshold for 
B-cell activation (23, 24). MRL/MpJlpr/lpr mice spontaneously 
develop an autoimmune disorder resembling human SLE and 
the molecular defect underlying this phenotype is a mutation 
in the Fas gene, which encodes a cell surface receptor of the 
TNF receptor superfamily that is important in apoptosis of lym-
phocytes (25, 26). We hypothesized that the introduction of the 
Fcmr null mutation onto the autoimmune-prone Faslpr/lpr back-
ground would affect the autoimmune process depending on 
the balance of protective IgM versus pathologic IgG auto-anti-
bodies. Our results indicate that Fcmr deficiency affects the 
kinetics and magnitude of auto-antibody production, but has 
no obvious impact on the B6.MRL Faslpr/lpr-lupus-like nephritis.
Methods
Mice
The generation and characterization of Fcmr−/− (Fcmr KO) 
mice on a C57BL/6 (B6) background has been described pre-
viously (11). B6.MRL Faslpr/lpr (B6/lpr) mice were purchased 
from the Jackson Laboratory (Bar Harbor, ME, USA). Fcmr 
KO mice were crossed with B6/lpr mice and the resultant 
F1 offspring were then intercrossed to generate F2 offspring. 
F2 siblings with appropriate genotype (i.e. Fcmr+/−/Faslpr/lpr or 
Fcmr−/−/Fas+/lpr) were then mated to generate Fcmr−/−/Faslpr/lpr 
and Fcmr+/+/Faslpr/lpr mice, hereafter designated, respectively, 
as FcμR(−) and FcμR(+) B6/lpr mice. The Fcmr and Fas gen-
otypes were determined by genomic PCR of tail DNA using 
a diagnostic set of primers: (i) 5′-ctgtagggctgaggctgggctg-
gtgacagg-3′ (forward), 5′-cgatggctaatatggcaatagtatgg-
gatg-3′ (reverse) and 5′-cttctctcccatagtgtgggccatggtggc-3′ 
(reverse) corresponding to the 5′-flanking and 3′-flanking 
Fcmr exons 2 and 5, respectively (11), and (ii) 5′-gtaaataatt-
gtgcttcgtcag-3′ (forward), 5′-caaatctaggcattaacagtg-3′ 
(reverse) and 5′-tagaaaggtgcacgggtgtg-3′ (reverse) cor-
responding to the 5′ and 3′ Fas intron 2 and the inserted 
early transposable element (Faslpr), respectively, according 
to the vendor’s protocol. FcμR(−) and FcμR(+) B6/lpr mice 
were maintained along with wild type (WT) control mice in 
filter-topped isolator cages at our animal facility and only 
female mice were used in the present studies. Genomic 
PCR analysis with microsatellite markers of chromosome 1 
[D1Mit419 (120.7 Mb from the centromere) and D1Mit268 
(157.4 Mb)] was performed to determine the genotype 
of the Fcmr (130.9 Mb), major lupus susceptibility locus 
(168.4–177.7 Mb) and Fcgr2b (171.0 Mb). All studies involv-
ing animals were conducted with approval of the University 
of Alabama at Birmingham institutional animal care and use 
committee.
RT–PCR
To confirm the lack of full-length FcμR transcripts in FcμR(−) 
B6/lpr mice, RT–PCR was performed as previously described 
(11). In brief, total RNA isolated from spleen was converted to 
first-strand cDNA before PCR amplification using a set of prim-
ers corresponding to the translation start and termination sites 
of the FcμR cDNA (forward, 5′-cctgtggagctcacagtctcag-3′ 
and reverse, 5′-cccagtgtagaacattgaagatg-3′). Amplification 
of the activation isoform of the paired immunoglobulin-like 
receptors (PIR-A) with a set of primers (forward, 5′-cctgtg-
gagctcacagtctcag-3′ and reverse, 5′-cccagtgtagaacattgaa-
gatg-3′) was performed as a control.
ELISA
Blood was withdrawn via the submandibular vein of naive ani-
mals at 10, 20 and 50 weeks of age. Sera were collected and 
stored at −80°C until assays were performed. Serum titers of 
IgM and IgG auto-antibodies against dsDNA, chromatin or 
Smith (Sm)/ribonuclear protein (RNP) antigen (ImmunoVision, 
Springdale, AR, USA) as well as serum concentrations of 
total IgM, IgG and IgA were assessed by ELISA as previously 
described (11).
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Flow cytometry
Spleen, cervical lymph nodes (LNs) and femurs were 
removed from 20-week-old naive mice; spleen and LNs were 
weighed and a piece of known weight was excised and sin-
gle cell suspensions were prepared from the piece of the 
excised tissues as previously described (11). The total cell 
numbers were assessed using the following formula: total cell 
numbers =  [(cell number in the cell suspension)/(weight of 
the piece of organ for cell preparation)] × (weight of the entire 
organ). For flow cytometric analysis, cells were first incubated 
with a mixture of anti-FcγRII/III (Ab93) (27) and anti-FcγRIV 
(9E9) (28) or aggregated human IgG for blocking all FcγRs, 
and then with a combination of the following fluorochrome-
labeled mAbs: FITC-labeled, anti-CD3 (145-2C11) and anti-
CD19 (1D3) mAbs, PE/Cy7-labeled, anti-CD23 (B3B4) and 
anti-CD11b (M1/70) mAbs, allophycocyanin (APC)-labeled, 
anti-CD4 (RM4-5) and anti-CD5 (53–7.3) mAbs purchased 
from eBioscience (San Diego, CA, USA); PE-anti-CD8 mAb 
(53–6.7), PerCP-anti-B220 mAb (RA3-6B2), APC-labeled, 
anti-CD138 (281–2) and anti-CD21/CD35 (7G6) mAbs from 
BD Biosciences (San Jose, CA, USA), PE-labeled, anti-
CD49d/integrin α4 (9C10), anti-CD29/integrin β1 (HMβ1-
1), anti-CD11a/integrin αL (2D7) and anti-CD18/integrin β2 
(M18/2) mAbs from BioLegend (San Diego, CA, USA). In 
some experiments, cells were incubated with biotinylated, 
anti-FcµR (MM3) or isotype-matched control mAb, washed 
and the bound biotinylated mAbs were detected by addi-
tion of PE-streptavidin (Southern Biotechnology Associates, 
Birmingham, AL, USA) as described previously (11). Stained 
cells with the light characteristics of lymphocytes and mac-
rophages were analyzed using an Accuri C6 flow cytometer 
(BD Biosciences). The flow cytometric data were analyzed 
with FlowJo software (TreeStar, Ashland, OR, USA).
Histopathological and immunohistological analyses
A portion of each organ (kidneys, liver, spleen, LNs and 
lungs) removed at 20 and 50 weeks of age was fixed in 10% 
neutral-buffered formalin, dehydrated, treated with xylene, 
embedded in paraffin, sectioned and stained with H&E or 
periodic acid-Schiff (PAS) for histopathological analysis. 
Another portion of kidney and spleen tissues was embedded 
in optimum cutting temperature compound, snap-frozen in 
dry ice-acetone, cut in 4–6 μm thickness with a cryostat, fixed 
in acetone and rehydrated in PBS. Sections were incubated 
with appropriate concentrations of fluorochrome-labeled anti-
bodies specific for mouse IgM (TI-2020; Vector Laboratories, 
Burlingame, CA, USA), IgG (A-11001; Life Technologies Co., 
Carlsbad, CA, USA), IgA or C3 (sc-3695 or 11H9; Santa 
Cruz Biotechnology). The immunostained tissue sections 
were examined by Olympus FV 1000 confocal fluorescence 
microscopy or Leica/Leitz DMRB microscope. Images of 10 
randomly selected glomeruli from each mouse were acquired 
with the same detector sensitivity and the deposition of immu-
noglobulins and C3 in the selected areas was quantitatively 
assessed as the fluorescence intensity by using the KS400 
image analysis system (version 4.0, Carl Zeiss Vision) as pre-
viously described (29). Two to three different investigators 
performed histopathological and immunohistological analy-
ses of these tissue sections in a blind fashion.
Blood urea nitrogen assay
Blood urea nitrogen (BUN) was measured in duplicate using 
a urea assay kit (Synchron LX Systems, Beckman Coulter 
Reference 442750) according to the manufacturer’s recom-
mendation except for the following modifications: 190 μl of 
reagent A, 10 μl of reagent B and 2 μl of serum or stand-
ard. The reaction was monitored at 340 nm after 20–30 min of 
incubation.
Statistical analysis
All data were analyzed with the Mann–Whitney test using 
GraphPad Prism 5 (version 5.04, La Jolla, CA, USA), and 
a P value of <0.05 was defined as statistically significant. 
Differences in group survival were analyzed using Mantel–
Cox Log-rank P test.
Results
A rapid increase in serum auto-antibody titers in FcμR(−)  
B6/lpr mice
It has recently been shown from studies of Fcmr KO mice by 
us and others that FcμR plays an important regulatory role in 
IgM homeostasis, as evidenced by elevation of serum IgM 
levels and natural auto-antibody titers of both IgM and IgG 
isotypes in naive mutant animals (11, 12, 19). To determine 
whether the FcμR deficiency affects autoimmune processes, 
FcμR(−) or FcμR(+) B6/lpr mice were generated. The ablation 
of Fcmr in FcμR(−) B6/lpr mice was confirmed by genomic 
PCR and the absence of full-length FcμR transcripts and 
proteins (Fig.  1). Genomic PCR analysis of FcμR(−) B6/lpr 
mice with microsatellite DNA markers revealed that D1Mit419 
(120.7 Mb), which is close to the Fcmr (130.9 Mb), was of 129 
origin, while D1Mit268 (157.4 Mb) and the Fcgr2b (171.0 Mb) 
were of B6 origin, indicating the B6 origin of the major lupus 
susceptibility locus, Sle16 identified in distal chromosome 1 
of the 129 strain (30, 31).
We then assessed serum auto-antibody titers in FcμR(−) 
and FcμR(+) B6/lpr as well as in WT B6 female mice at three 
different ages by ELISA using two representative self-anti-
gens, dsDNA (Fig.  2A) and chromatin (see Supplementary 
Figure S1, available at International Immunology Online). At 
10 weeks of age, serum IgM and IgG auto-antibody titers to 
both auto-antigens were clearly elevated in FcμR(−) B6/lpr 
mice as compared with the other groups of mice. At 20 weeks 
of age, a similar trend was still observed with IgM auto-anti-
bodies to both antigens, but not with IgG auto-antibodies, 
although IgG antibodies in FcμR(−) and FcμR(+) B6/lpr mice 
were elevated as compared with WT mice. At 50 weeks of 
age, the trend became less clear, but FcμR(−) B6/lpr mice still 
had higher titers of anti-chromatin antibodies of both isotypes 
compared with other groups of mice. A similar, but less clear, 
trend was also observed with IgG2b, IgG2c and IgA auto-
antibodies against dsDNA (see Supplementary Figure S1B, 
available at International Immunology Online). In addition to 
the above auto-antibody titers, the serum levels of total IgM 
and IgA in FcμR(−) B6/lpr mice were also higher than those 
in the other mice and were increased with age (Fig. 2B). By 
contrast, the serum level of total IgG was comparable in both 
groups of B6/lpr mice during the entire period of analysis, 
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suggesting that IgG auto-antibodies elevated at an early age 
in FcμR(−) B6/lpr mice constitute a minor fraction of the total 
serum IgG. Collectively, these findings suggest that the abla-
tion of Fcmr in B6/lpr mice leads to a rapid increase in serum 
auto-antibodies of IgM and, to a lesser extent, IgG isotypes 
at a relatively early stage in life as compared with control 
B6/lpr mice.
Altered B-cell subsets in FcμR(−) B6/lpr mice
In our previous studies, the expression of mouse FcμR was 
shown to be restricted to B-lineage cells, from immature B 
to plasmablasts, except for a transient down-modulation dur-
ing the germinal center (GC) reaction and that Fcmr abla-
tion had no significant effect on overall B- and T-lymphocyte 
development except for a 4-fold reduction in marginal zone 
(MZ) B cells and a 2-fold increase in splenic B1 cells (11). 
To determine if the FcμR deficiency leads to alterations in 
lymphocyte development in B6/lpr mice and to gain insight 
to the mechanism of altered auto-antibody production in the 
absence of FcμR, we compared various cell populations in 
~20-week-old mice by flow cytometry. There was significant 
splenomegaly in both FcμR(+) [255 ± 129 mg spleen weight 
(mean ± 1 SD)] and FcμR(−) (218 ± 56 mg) B6/lpr mice as 
compared with WT mice (78 ± 12 mg). This was also the 
case for the total cell numbers recovered from these tissues 
(Table 1). Representative immunofluorescent profiles and cell 
numbers of each subset are shown in Fig. 3A and Table 1, 
respectively.
In spleen, the numbers of total B- and B2-cell populations 
were elevated by ~2-fold in FcμR(+) B6/lpr mice but were 
comparable between FcμR(−) B6/lpr and WT mice (Fig. 3B, 
top), suggesting normalization of the splenic B2-cell com-
partment by introduction of FcμR deficiency into B6/lpr mice. 
By contrast, the number of B cells with the unique surface 
phenotype of CD5−/CD11b+, equivalent to the B1b cells in 
peritoneal cavity, was markedly (8- to ~10-fold) increased 
in both FcμR(−) and FcμR(+) B6/lpr mice as compared with 
the WT mice. Likewise, B1a cells were also expanded in 
both groups of B6/lpr mice, though the difference between 
FcμR(−) B6/lpr and WT mice was statistically insignificant. 
Interestingly, we noted that the B1a/B1b ratio was inverted 
in B6/lpr mice irrespective of FcμR expression, as com-
pared with WT mice (Table 1). [Similar hierarchies were also 
observed in subsets classified by other markers (i.e. follicular 
and newly formed B-cell subsets; see Supplementary Figure 
S2, available at International Immunology Online).] Notably, 
the number of MZ B cells in FcμR(−) B6/lpr mice was clearly 
lower than that of either FcμR(+) B6/lpr or WT mice, suggest-
ing that the reduced MZ B-cell compartment in the absence 
of FcμR (11) is not normalized on the B6/lpr background (see 
Fig. 3A and B, middle). The number of mature plasma cells 
was markedly elevated by ~100-fold in FcμR(+) B6/lpr mice 
and by ~40-fold in FcμR(−) B6/lpr mice, compared with the 
WT mice, but the difference in both genotypes of B6/lpr mice 
was statistically insignificant due to the large individual vari-
ability (Fig.  3B, middle). The numbers of conventional (i.e. 
CD3+/B220−) T cells were also comparable between FcμR(+) 
and FcμR(−) B6/lpr mice, but were significantly elevated 
as compared with WT mice (see Supplementary Figure S2, 
available at International Immunology Online).
Essentially, similar results were also observed with remark-
ably enlarged LN tissues in both genotypes of B6/lpr mice. 
These included marked increases in the numbers of plasma 
cells, B1b, B1a and B2 cells as well as in the atypical T cells, 
defined as CD3+/B220+/CD4−/CD8− and known to be unique 
for the Faslpr/lpr mutation, and in conventional CD4 T and CD8 T 
cells (see Supplementary Figure S3, available at International 
Immunology Online). These results indicate that lack of FcμR 
expression on B-lineage cells does not affect the develop-
ment of atypical T cells in B6/lpr mice. In bone marrow (BM), 
the CD19+ B-lineage cells in FcμR(−) B6/lpr mice were sig-
nificantly reduced as compared with FcμR(+) B6/lpr and 
WT mice and this reduction was more evident in the CD19hi 
recirculating mature B cells than the CD19lo pro-B/pre-B and 
immature B-cell compartments (Fig. 3B, bottom). Unlike the 
plasma cells in peripheral lymphoid tissues, the number of 
mature plasma cells in the BM from FcμR(−) B6/lpr mice was 
reduced to the normal level of WT mice. Collectively, these 
Fig. 1. Lack of FcμR expression in Fcmr−/− B6/lpr mice. (A) 
Genotyping of offspring of Fcmr−/− C57BL/6 and B6.MRL Faslpr/lpr 
mice. Tail DNA was subjected to genomic PCR using diagnostic sets 
of primers to determine the genotype of Fcmr and Fas in individual 
mice. Representative genotyping data are shown. The normal (WT) 
and targeted (KO) alleles of Fcmr give rise to 570 and 730-bp PCR 
products, respectively. The WT and mutant (Lpr) alleles of Fas are 
179 and 217 bp, respectively. (B) RT–PCR analysis. Total RNAs iso-
lated from spleen of Fcmr+/+ (lanes 1 and 4) or Fcmr−/− (lanes 2 and 
5) B6/lpr mice and control WT mice (lanes 3 and 6) were subjected 
to RT–PCR and amplified products of FcμR (lanes 1–3) and control 
PIR-A (lanes 4–6) were electrophoresed in 0.7% agarose and stained 
with ethidium bromide. Lane 7 is a PCR control without a first-strand 
cDNA template. Note the lack of full-length FcμR transcripts (1283 bp) 
in Fcmr−/− B6/lpr mice and presence of PIR-A transcripts (253 bp). (C) 
Flow cytometric analysis of cell surface FcμR. Splenocytes from the 
indicated mice were first incubated with FcγR-blocking mAbs and 
then with biotinylated, anti-FcμR (lines) or isotype-matched control 
mAb (shaded) and FITC-anti-CD19 mAb. The bound biotinylated 
mAbs were detected by addition of PE-streptavidin. CD19+ B cells 
were gated and examined for their expression of FcμR.
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Fig. 2. Serum levels of IgM and IgG auto-antibodies and of total IgM, IgG and IgA.  Sera were collected from WT B6 (n = 5–24; closed cir-
cles), FcμR(+) B6/lpr (n = 13–23; closed inverted triangles) and FcμR(−) B6/lpr (n = 16–28; closed diamonds) female mice at the age of 10 
weeks (top), 20 weeks (middle) and 50 weeks (bottom), and were subjected to ELISA for assessment of titers of antibody against dsDNA 
(A). Concentrations (μg/ml) of total serum IgM, IgG and IgA are also depicted (B). Each symbol represents data from an individual mouse. 
*P < 0.05, **P < 0.01 and ***P < 0.001, respectively.
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Fig. 3. Immunofluorescent assessment of cellular compartments in Fcmr−/− and control B6/lpr mice. (A) Representative immunofluorescence 
profiles. Splenocytes (top three rows) and LN cells (bottom row) isolated from WT B6 (left column), FcμR(+) B6/lpr (middle column) and FcμR(−) 
B6/lpr (right column) female mice at 20 weeks of age were first incubated with FcγR-blocking reagents and then with fluorochrome-labeled 
mAbs specific for the indicated surface markers. Stained cells with the light scatter characteristics of lymphocytes/macrophages were analyzed 
using an Accuri C6 flow cytometer. In the second and third rows, the CD19+ B cells were gated and examined for their expression of the indi-
cated surface markers. Numbers indicate percentages of cells. Note (i) a sizable population of CD11b+/CD5− B cells, (ii) marked expansion of 
CD3+/B220+ atypical T cells in both FcμR(+) and FcμR(−) B6/lpr mice and (iii) a clear reduction of CD21+/CD23− MZ B cells in FcμR(−) B6/lpr 
mice. (B) Total cell numbers in each population in spleen (top two rows) and BM (bottom row) from WT B6 (closed circles), FcμR(+) B6/lpr 
(closed inverted triangles) and FcμR(−) B6/lpr (closed diamonds) mice (five in each group). Each symbol represents data from an individual 
mouse. The horizontal bar indicates the arithmetic mean. *P < 0.05 and **P < 0.01, respectively. Note (i) normal levels of splenic B and B2 cells 
and marked reduction of MZ B cells in FcμR(−) B6/lpr mice, (ii) comparable levels of B1b and B1a cells as well as plasma cells in both FcμR(+) 
and FcμR(−) B6/lpr mice and (iii) significant reduction of BM mature B cells and normal levels of BM plasma cells in FcμR(−) B6/lpr mice.
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findings suggest that the ablation of Fcmr in B6/lpr mice 
leads to a reduction in splenic B cells including the B2 and 
MZ B-cell subsets and BM mature B and plasma cells, but 
does not significantly affect the markedly expanded plasma 
cell compartments in spleen and LNs or the B1-cell subsets, 
when compared with FcμR(+) B6/lpr mice.
Increase in anti-Sm antibody titers and Mott cell formation 
in Fcmr-deficient B6/lpr mice 
As described above, FcμR(−) B6/lpr mice had significantly 
higher titers of serum auto-antibodies of IgM and, to a lesser 
extent, IgG isotype, but equivalent numbers of B1 cells and 
markedly reduced numbers of MZ B cells, when compared 
with FcμR(+) B6/lpr mice. To test the possibility that MZ B cells 
rapidly differentiate into plasma cells in the absence of FcμR, 
we assessed the antibody titer to another self-antigen Sm/
RNP, including FcμR(−) B6 mice as another control. We chose 
the antigen because MZ B cells preferentially respond to 
first encountering Sm/RNP-containing apoptotic cells in their 
unique anatomical site (32, 33). Among four groups of mice 
[FcμR(+) or (−) B6 and FcμR(+) or (−) B6/lpr mice], IgM anti-
Sm antibody titers were the highest in FcμR(−) B6/lpr mice 
at 10 weeks of age, but later were clearly elevated in three 
groups of mice in the order: FcμR(−) B6/lpr = FcμR(−) B6 > 
FcμR(+) B6/lpr (Fig. 4A). By contrast, IgG anti-Sm antibody 
titers were more slowly increased in both genotypes of B6/lpr 
mice only. Thus, an early increase in IgM anti-Sm antibodies 
appears to result from synergy of both Fcmr-ablation and Fas-
deficiency, but the Fcmr-ablation alone clearly contributes 
to an increase in IgM anti-Sm antibody production. The sur-
face expression of adhesion molecules [leukocyte function- 
associated antigen 1 (LFA1) (αLβ2) and VLA4 (α4β1)], which 
are known to be critically involved in the localization and reten-
tion of MZ B cells in the marginal sinuses (34), was compa-
rable regardless of the FcμR expression (data not shown), 
ruling out the possibility of a homing impairment of MZ B-cell 
precursors in FcμR-deficient mice. Collectively, these findings 
suggest that because MZ B cells may recognize blood-borne 
antigens by cross-linkage of multiple receptors such as the 
BCR and TLRs, FcμR regulates their rapid differentiation into 
plasma cells in red pulp.
Next, when formalin-fixed, paraffin-embedded tissue sec-
tions of spleen and LNs were stained with PAS, we found 
an intriguing difference. As PAS, unlike H&E, does not stain 
erythrocytes, cellular changes in the red pulp of spleen are 
more easily detectable. Indeed, strongly PAS+ plasma-like 
cells were much more frequently observed in such areas of 
spleen as well as in the medulla and extrafollicular areas of 
LNs in both groups (B6/lpr and B6) of FcμR(−) mice as com-
pared with FcμR(+) B6/lpr or B6 mice (Fig. 4B). These were 
Mott cells, an aberrant form of plasma cells in which large 
amounts of immunoglobulin accumulate in rough endoplas-
mic reticulum (ER)-bound vesicles as intra-cytoplasmic inclu-
sions called Russell bodies. The majority of the Mott cells in 
FcμR(−) mice were IgM+, but a few were IgG+, indicating no 
isotype restriction of Mott cell formation in the mutant mice. 
Collectively, these findings suggest that the FcμR-deficiency 
is clearly involved in the augmented anti-Sm antibody pro-
duction and Mott cell generation.
FcμR deficiency has no effect on the lupus-like nephritis 
associated with B6/lpr mice
To determine whether the early increase in serum auto-anti-
body titers and alterations of certain lymphocyte subsets in 
FcμR(−) B6/lpr mice affect the autoimmune pathology, we 
performed immunohistopathological examination of major 
organs in FcμR(−) or FcμR(+) B6/lpr mice at two different 
ages. At ~20 weeks of age, in both groups of mice, the patho-
logical changes in glomeruli were generally minimal and no 
significant changes were observed in the urinary tubules. 
Immunohistological analysis of glomeruli revealed weakly 
stained IgM deposits in both groups of mice. Perivascular 
lymphoid infiltration in the interstitium was detectable in only 
one out of five mice in each group. Perivascular lymphoid 
infiltration in liver was observed in three FcμR(+) mice and 
in one FcμR(−) B6/lpr mouse. By contrast, at ~50 weeks of 
age, many glomeruli in all mice of both groups were equally 
affected to variable degrees, including mesangial cell pro-
liferation, increased mesangial matrix with homogeneous 
PAS+ substances and focal necrosis (Fig. 5A), but very few 
changes in urinary tubules were observed [1/7 for FcμR(+) 
and 0/8 for FcμR(−) B6/lpr mice]. Perivascular interstitial 
lymphoid infiltration was also observed in some mice of both 
groups [4/7 for FcμR(+) and 3/8 for FcμR(−) B6/lpr mice]. 
Immunohistological analysis of glomeruli revealed variable 
deposition of IgM, IgG, IgA and C3 primarily in the mesan-
gium from both groups of mice (Figs 5B and 5C). When the 
fluorescence was assessed quantitatively, no significant 
differences were observed between FcμR(+) and FcμR(−) 
B6/lpr mice (Fig. 5C). In liver, variable degrees of perivascu-
lar lymphoid infiltration [6/7 for FcμR(+) and 7/8 for FcμR(−) 
B6/lpr] and of piecemeal necrosis of hepatocytes [5/7 for 
FcμR(+) and 8/8 for FcμR (−) B6/lpr] were observed in both 
groups of mice. Tiny perivascular lymphoid infiltrates were 
also observed in lungs [3/7 for FcμR(+) and 6/8 for FcμR(−) 
B6/lpr]. These findings suggest that the presence or absence 
of FcμR had no significant effect on the autoimmune pathol-
ogy associated with B6/lpr mice.
To evaluate renal function, levels of BUN were assessed. 
As shown in Fig. 6A, these were comparable in both groups 
of B6/lpr mice at either 20 or 50 weeks of age and not sig-
nificantly increased as compared with those of WT B6 mice. 
This is consistent with the histopathological findings that 
nearly three quarters of the B6/lpr mice, irrespective of FcμR 
expression, had many prominent glomerular lesions but very 
few urinary tubular changes. Notably, there were also no sig-
nificant differences in lifespan between FcμR(−) and FcμR(+) 
B6/lpr mice, as 20% of both groups of mice died during the 
first year of life (Fig. 6B). [Unfortunately, the cause of death, 
e.g. asphyxia due to massive enlargement of cervical LNs, 
hemodynamic changes or cardiac failure due to generalized 
lymphadenopathy and splenomegaly, renal insufficiency due 
to severe glomerulonephritis, or other reasons, was unclear.]
Discussion
The results from previous studies by us and others have dem-
onstrated that FcμR has an important role in IgM homeostasis 
as evidenced by significant increases in serum levels of IgM 
and natural auto-antibodies of both IgM and IgG isotypes in 
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naive Fcmr KO mice (11, 12, 19). The goal of the present 
study was to determine the impact of Fcmr ablation in Fas-
deficient autoimmune-prone B6/lpr mice, which have a milder 
form of lupus-like disease than MRL Faslpr/lpr mice (25, 35). 
Our hypothesis was that the introduction of the Fcmr null 
mutation onto B6/lpr background would affect the autoim-
mune process depending on the balance of protective IgM 
versus pathologic IgG auto-antibodies. Fcmr deficiency in 
Fig. 4. High titer of anti-Sm antibody and enhanced Mott cell formation in the absence of FcμR. (A) Assessment of anti-Sm antibody. Serum 
levels of anti-Sm antibodies in FcμR (+) B6 (closed circles), FcμR(−) B6 (n = 17–27; closed triangles), FcμR(+) B6/lpr (closed inverted trian-
gles) and FcμR(−) B6/lpr (closed diamonds) female mice were similarly assessed by ELISA as described in the Fig. 2 legend. (B) Mott cells. 
Left: Representative PAS-stained spleen sections from FcμR(−) B6/lpr mice of 20 weeks of age depicting strongly PAS+ Mott cells (upper) and 
representative immunofluorescent staining of Mott cells with FITC anti-μ antibodies with short (lower left) and long (lower right) exposure. Right: 
Number of Mott cells per mm2 of spleen and LNs from WT B6 (closed circles), FcμR(−) B6 (closed triangles), FcμR(+) B6/lpr (closed inverted 
triangles) and FcμR(−) B6/lpr (closed diamonds) mice (n = 3–6 in each group). *P < 0.05, **P < 0.01 and ***P < 0.001.
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B6/lpr mice led to (i) a rapid increase in serum auto-antibody 
levels of IgM and, to a lesser extent, IgG isotypes at a rela-
tively early age, (ii) normalization of the splenic B2 subset 
and the BM B-lineage cell compartment, mostly mature B 
cells, (iii) a marked reduction of the MZ B-cell subset and (iv) 
increased formation of Mott cells, an aberrant form of plasma 
cells. The reduction of MZ B cells in the absence of FcμR 
seemed to be due to their rapid differentiation into plasma 
cells, as evidenced by an increase in serum IgM anti-Sm anti-
bodies in both groups (B6/lpr and B6) of FcμR(−) mice. The 
FcμR deficiency, however, did not affect the severity of glo-
merulonephritis, renal function or survival.
Serum auto-antibody titers of both IgM and IgG isotypes, 
though the latter was less evident, were consistently higher 
in FcμR(−) B6/lpr mice than FcμR(+) B6/lpr mice during the 
entire period examined. Serum levels of total IgM and IgA, 
but not of total IgG, were also higher in FcμR(−) B6/lpr than 
FcμR(+) B6/lpr mice. On the other hand, the total CD138+ 
plasma cell numbers in all three tissues examined (spleen, 
LNs and BM) were consistently lower in FcμR(−) B6/lpr mice 
than FcμR(+) B6/lpr mice, although the difference was not 
statistically significant. This apparent discrepancy cannot 
easily be explained at moment. In our previous studies, the 
half-life of injected IgM was identical regardless of the FcμR 
expression, suggesting no obvious involvement of the B-cell 
FcμR in IgM catabolism (11). The half-life of secreted IgM 
antibody in mice is estimated as ~2 days, similar to that of 
short-lived plasmablasts (<3 days), which express FcμR on 
their cell surface (36). Thus, the involvement of FcμR in anti-
body secretion by plasma cells as the consequence of B-cell 
responses to foreign or self-antigens may be very complex 
and occurring at multiple levels and remains to be further 
explored.
Another interesting feature of plasma cells in B6/lpr 
mice was their massive expansion (~40- to ~3,800-fold) in 
peripheral sites (spleen and LNs) but only 2-fold in the BM, 
confirming the concept of the limited capacity of the BM 
microenvironment for plasma cells, especially the long-lived 
variety. Furthermore, the peripheral expansion occurred in 
both FcμR(+) and FcμR(−) B6/lpr mice, whereas the BM 
expansion was only observed in FcμR(+) B6/lpr mice. In this 
regard, an inhibitory FcγR, FcγRIIb, is also expressed on BM 
Fig. 5. Pathological changes of kidney. (A) Representative PAS-stained kidney sections from FcμR(+) (left panel) and FcμR(−) (right panel) 
B6/lpr mice of 50 weeks of age at two different magnifications. Scale bars indicate 50 μm (upper panel) and 20 μm (lower panel). Note mesan-
gial cell proliferation and increase mesangial matrix with homogeneous PAS+ substances in both groups of mice. (B) Representative immuno-
fluorescence images of glomerular deposition of IgM (top), IgG (middle) and C3 (bottom) from FcμR(+) (left panel) and FcμR(−) (right panel) 
B6/lpr mice. Note the presence of immune deposits primarily in the mesangium of both groups of mice. (C) Mean fluorescence intensity (MFI) of 
deposition of IgM, IgG, IgA and C3 in glomeruli from FcμR(+) (closed inverted triangles) and FcμR(−) (closed diamonds) B6/lpr mice. Results 
are shown as arbitrary units.
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plasma cells, and its engagement with IgG immune com-
plexes induces apoptosis through an antigen-independent 
mechanism, thereby reducing the number of pre-existing 
plasma cells in the limited BM niche and creating space 
for newly formed plasma cells to take up residency and to 
become part of the long-lived plasma cell repertoire (37). 
Notably, however, autoimmune-prone mice including MRL 
Faslpr/lpr express almost negligible levels of surface FcγRIIb 
on GC B and BM plasma cells (37–39), hence suggesting 
the existence of additional regulator(s) that must control the 
homeostasis of BM plasma cells more strongly than FcγRIIb. 
Further studies are required to determine whether FcμR and 
its signals are involved in the differentiation and/or survival of 
plasmablasts.
The findings that several B-cell subsets in B6/lpr mice were 
affected by FcμR deficiency could be important with regard to 
the potential function of this receptor. Fcmr ablation in B6/lpr 
mice led to a reduction of the number of splenic B2 (or FO) B 
cells to the normal level, but did not alter the B1 B-cell pop-
ulations. By contrast, in our previous studies, we observed 
that Fcmr ablation in B6 mice resulted in a 2-fold increase in 
splenic B1 B cells (11). Interestingly, similar changes, ~25% 
reduction of the FO B-cell number and a 2-fold increase in B1 
B cells, have been demonstrated in the spleen of mice unable 
to secrete IgM (μs−/−) (40, 41). These findings thus suggest that 
despite the equal surface FcμR levels on both B2- and B1-cell 
subsets, FcμR or its signals may differentially regulate the 
homeostasis of B2 versus B1 B cells. In support of this idea, it 
has been well documented that upon engagement of the BCR, 
B2 B cells exhibit robust intracellular Ca2+ mobilization and cell 
proliferation, whereas B1 B cells display modest Ca2+ mobiliza-
tion, impaired proliferation and increased apoptosis (42). The 
present analysis also revealed a marked (~10- to ~100-fold) 
increase of B1b B cells, defined as CD5−/CD11b+, in spleen 
and LNs in B6/lpr mice regardless of FcμR expression. B1b B 
cells, a minor subset of mature B cells, express very low levels 
of FcμR on their cell surface and are known to mediate long-
lasting antibody responses to T-cell-independent antigens 
expressed on many bacterial pathogens (43). It should be 
elucidated whether the increase of B1b B cells is restricted to 
Fas-deficient MRL Faslpr/lpr mice or is common to other autoim-
mune-prone mice. In this regard, an unusual type of mature B 
cell (CD11c+/CD11b+/CD5−/lo/CD21−/CD23−) that accumulates 
in aged female mice as a result of stimulation through TLR7 
or TLR9 was recently identified and shown to be important for 
the development of autoimmunity (44, 45). It will be of interest 
to determine if this population, termed age-associated B cells, 
includes the B1b B cells that we describe here.
Another remarkable finding is the marked reduction of MZ 
B cells in FcμR(−) B6/lpr mice as compared with FcμR(+) 
B6/lpr mice, similar to our previous findings with FcμR(−) B6 
mice (11). By contrast, the number of MZ B cells in μs−/− mice 
is increased by ~3-fold and this increase can be normalized 
by passive administration of natural or polyclonal, but not 
monoclonal, IgM preparations (41). It remains unclear, how-
ever, whether this normalization results from differentiation of 
MZ B cells into plasma cells or apoptosis of MZ B cells upon 
possible engagement of multiple receptors including TLRs 
with natural IgM. To explore the basis for reduction of the MZ 
B-cell compartment in the absence of FcμR, we first exam-
ined their surface expression of adhesion molecules LFA1 
and VLA4, which are known to be crucial for their precursor’s 
homing to the marginal sinus (34). Both adhesion molecules 
were equally expressed irrespective of FcμR expression, rul-
ing out the possibility for homing impairment of MZ B-cell 
precursors in such mutant mice. Next, we assessed serum 
antibodies against an Sm/RNP antigen because the results 
from analysis of immunoglobulin-transgenic mice suggested 
Fig. 6. Kidney function and survival. (A) Results show the BUN levels (mg/dl) in WT B6 (n = 5–13; closed circles), FcμR(+) B6/lpr (n = 8–16; 
closed inverted triangles) and FcμR(−) B6/lpr (n = 15–21; closed diamonds) mice at 20 (top) and 50 (bottom) weeks of ages. Each symbol rep-
resents data from an individual mouse. The shaded area represents the range within 2 SDs of the mean of WT B6 mice. (B) Survival of FcμR(+) 
B6/lpr (n = 17; unfilled circles) and FcμR(−) B6/lpr (n = 20; filled circles) mice up to 50 weeks of age.
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that while both B1 and MZ B cells have the potential to pro-
duce anti-Sm antibodies, the MZ B cell was found to be the 
major source as a consequence of its interaction with apop-
totic cell-ingested dendritic cells in the marginal sinuses (32, 
33). In the present studies, serum titers of IgM, but not IgG, 
anti-Sm antibodies at 10 weeks of age were increased by 
>10-fold in FcμR(−) B6/lpr mice as compared with FcμR(+) 
B6/lpr mice. This finding, along with the result of equivalent 
number of B1 cells in both genotypes of B6/lpr mice, sug-
gested that the reduced number of MZ B cells in both groups 
(B6/lpr and B6) of FcμR(−) mice resulted from their rapid dif-
ferentiation into plasma cells secreting anti-Sm antibodies. 
This in turn implies that FcμR and its signals may play an 
important regulatory role in the differentiation of MZ B cells 
into plasma cells secreting natural IgM antibodies against 
apoptotic cells.
The finding of enhanced Mott cell formation in the 
absence of FcμR is also intriguing. Mott cells containing 
immunoglobulin aggregates termed Russell bodies are 
rarely observed in normal lymphoid tissues, but are found 
in various pathological conditions, including neoplasms, 
inflammatory diseases and autoimmune disorders (46–50). 
Several mechanisms for Mott cell formation have been sug-
gested: (i) structural alterations of immunoglobulin heavy 
chains (HCs) preventing their appropriate processing; (ii) 
impairment of immunoglobulin light chains, which normally 
prevent immunoglobulin HC chain aggregation; and (iii) 
inability to degrade or to export immunoglobulin, leading 
to its aggregation. As to the molecular basis for enhanced 
Mott cell formation in FcμR-deficient mice, the possibility 
that FcμR may be involved in the assembly process of nas-
cent immunoglobulin μ HCs in the ER is unlikely because 
IgG+ Mott cells were also observed, albeit less frequently, 
in the mutant mice. There is a precedent that certain B-cell 
hybridomas accumulate IgM in the Golgi due to formation 
of IgM/glycosaminoglycan complexes and release of large 
spherical IgM complexes, termed spherons, of up to 2 μm 
in diameter (51, 52). Thus, it is possible that some of the IgM 
produced by plasma cells in both groups (B6/lpr and B6) 
of FcμR(−) mice may recognize determinant(s) on the ER 
membrane, thereby generating Mott cells. In support of this 
idea, it has been suggested that Mott cells predominantly 
occur in the B1-cell compartment (47, 49).
There is compelling evidence for a protective role of IgM in 
autoimmune processes. For example, in μs−/− mice, there was 
an increase in spontaneous autoimmunity as judged by the 
age-dependent development of serum IgG auto-antibodies 
and their glomerular deposition (53). When the μs−/− mice were 
crossed with MRL Faslpr/lpr mice, the resultant μs−/− MRL/lpr 
mice developed elevated serum levels of IgG auto-antibodies 
with glomerular deposition, suffered more severe glomeru-
lonephritis and succumbed to the disease at an earlier age 
as compared with control MRL/lpr mice (54). Thus, secreted 
IgM, including naturally produced IgM auto-antibody, appears 
to lessen the severity of autoimmune pathology associated 
with IgG auto-antibodies. Conversely, MRL/lpr mice defi-
cient in activation-induced deaminase, an enzyme required 
for immunoglobulin somatic hypermutation and class switch 
recombination, lacked IgG auto-antibodies but had elevated 
autoreactive IgM and experienced a significant reduction in 
glomerulonephritis and a dramatic increase in survival as 
compared with control MRL/lpr mice (55). These findings sug-
gest that IgM, including autoreactive IgM, may not promote 
nephritis but rather provides a protective role in MRL/lpr mice.
Given these precedents and our previous findings that 
Fcmr ablation led to an increase in the concentrations of pre-
immune serum IgM and natural auto-antibodies of both IgM 
and IgG isotypes (11), we expected that FcμR deficiency 
would have a major impact on the phenotype of B6/lpr mice. 
Indeed, compared with FcμR(+) B6/lpr mice, the increase in 
serum levels of IgM and IgG antibodies to dsDNA or chro-
matin in FcμR(−) B6/lpr mice was clearly evident as early as 
10 weeks. However, this difference became less dramatic, 
especially for IgG auto-antibodies, in older mice. The sever-
ity of glomerulonephritis, the renal function and the lifespan 
were all comparable between FcμR(−) and FcμR(+) B6/lpr 
mice. Thus, despite the early elevation of autoreactive IgM 
and IgG, the FcμR null mutation did not affect the Faslpr/lpr-
associated pathology. This is quite distinct from the strong 
association between the null mutation of the inhibitory 
FcγRIIb and risk for developing severe autoimmune mani-
festations; Fcgr2b-deficient B6/lpr mice developed severe 
systemic autoimmune diseases and died within 30–40 
weeks of age (56–58). However, it was also suggested that 
the chromosome 1 region around the Fcgr2b, called Sle16, 
contributed directly to the development of lethal lupus as 
determined by comparison of the severity of autoimmunity-
associated pathology between 129 ES-derived versus B6 
ES-derived Fcgr2b−/− mice, and that Fcgr2b was a modifier, 
rather than a causative gene, of autoimmune susceptibility 
(30, 31, 59, 60). Indeed, the absence of 129-derived Sle16 
locus in our FcμR(−) B6/lpr mice would explain why they 
failed to develop severe lupus-like autoimmune disease. 
Furthermore, it has also been suggested that autoreactive 
B cells rather than their products, the auto-antibodies, play 
a more essential role in developing autoimmune pathology, 
possibly by presenting auto-antigens to T cells (61, 62). In 
this regard, the cellular infiltrates in the renal interstitium 
and around the blood vessels, which are considered as 
T-cell mediated immune responses (61), were comparable 
between FcμR(−) and FcμR(+) B6/lpr mice. This finding in 
turn implies that unlike FcγRs, FcμR may not have a function 
in antigen presentation as suggested by Ouchida et al. (12), 
although the receptor is rapidly internalized into the lysoso-
mal compartment upon IgM binding (8).
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Supplementary data are available at International Immunology 
Online.
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